Innate Pharma
IPHA
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)
Categories
EPS for Innate Pharma (IPHA)
EPS in 2022: -$0.78
According to Innate Pharma 's latest financial reports the company's current EPS (TTM) is -$0.78. In 2022 the company made an earnings per share (EPS) of -$0.78 a decrease over its 2021 EPS that were of -$0.75.
EPS history for Innate Pharma from 2005 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 | -$0.78 | 4.6% |
| 2021 | -$0.75 | -24.98% |
| 2020 | -$1.00 | 186.89% |
| 2019 | -$0.35 | -707.12% |
| 2018 | $0.05720 | -105.35% |
| 2017 | -$1.07 | -541.28% |
| 2016 | $0.24 | -270.34% |
| 2015 | -$0.14 | -70.03% |
| 2014 | -$0.47 | 390.66% |
| 2013 | -$0.09667 | -8.65% |
| 2012 | -$0.11 | -57.03% |
| 2011 | -$0.25 | -48.58% |
| 2010 | -$0.48 | -40.32% |
| 2009 | -$0.80 | 24.76% |
| 2008 | -$0.64 | 22.34% |
| 2007 | -$0.53 | 16.95% |
| 2006 | -$0.45 | -7.23% |
| 2005 | -$0.48 |